Judith M Greer Selected Research

Neurotransmitter Receptors (Neurotransmitter Receptor)

11/2019	Is there a role for antibodies targeting muscarinic acetylcholine receptors in the pathogenesis of schizophrenia?
4/2014	Elevated levels of autoantibodies targeting the M1 muscarinic acetylcholine receptor and neurofilament medium in sera from subgroups of patients with schizophrenia.
2/2005	Immune dysregulation and self-reactivity in schizophrenia: do some cases of schizophrenia have an autoimmune basis?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Judith M Greer Research Topics

Disease

18	Multiple Sclerosis 08/2020 - 06/2004
9	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2017 - 09/2004
6	Autoimmune Diseases (Autoimmune Disease) 01/2017 - 02/2005
4	Schizophrenia (Dementia Praecox) 11/2019 - 02/2005
3	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 01/2015 - 05/2005
2	Central Nervous System Diseases (CNS Diseases) 01/2017 - 11/2008
2	Inflammation (Inflammations) 08/2014 - 10/2012
2	Ischemic Stroke 04/2014 - 05/2012
2	Disease Progression 04/2013 - 10/2012
1	Psychotic Disorders (Schizoaffective Disorder) 11/2019
1	Thyroid Diseases (Thyroid Disease) 01/2017
1	Demyelinating Diseases (Demyelinating Disease) 01/2017
1	Chronic Disease (Chronic Diseases) 01/2015
1	Hypoxia (Hypoxemia) 04/2014
1	Stroke (Strokes) 05/2012
1	Nervous System Diseases (Neurological Disorders) 05/2008
1	Peripheral Nervous System Diseases (PNS Diseases) 05/2005
1	Guillain-Barre Syndrome 05/2005
1	Chronic Progressive Multiple Sclerosis 01/2003
1	Friedreich Ataxia (Friedreich's Ataxia) 05/2002

Drug/Important Bio-Agent (IBA)

7	Myelin Proteolipid ProteinIBA 01/2020 - 06/2004
5	Peptides (Polypeptides)IBA 01/2017 - 03/2005
5	AntigensIBA 01/2017 - 06/2004
4	Proteins (Proteins, Gene)FDA Link 08/2020 - 02/2008
3	Neurotransmitter Receptors (Neurotransmitter Receptor)IBA 11/2019 - 02/2005
3	AutoantigensIBA 01/2017 - 02/2008
3	LigandsIBA 01/2017 - 03/2014
2	AntibodiesIBA 01/2020 - 11/2019
2	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 11/2019 - 04/2014
2	AutoantibodiesIBA 04/2014 - 02/2005
2	Biological ProductsIBA 04/2013 - 01/2012
2	Interleukin-6 (Interleukin 6)IBA 10/2012 - 05/2012
2	3' Untranslated Regions (3' UTR)IBA 05/2009 - 03/2009
2	GangliosidesIBA 05/2005 - 01/2003
1	Cholinergic Agents (Cholinergics)IBA 11/2019
1	Biomarkers (Surrogate Marker)IBA 11/2019
1	Antipsychotic Agents (Antipsychotics)IBA 11/2019
1	Leucine (L-Leucine)FDA Link 01/2017
1	Calcitonin Gene-Related PeptideIBA 01/2017
1	Thyrotropin Receptors (Thyrotropin Receptor)IBA 01/2017
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2017
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2017
1	EpitopesIBA 01/2017
1	Pharmaceutical PreparationsIBA 01/2015
1	Interleukin-17 (Interleukin 17)IBA 01/2015
1	HLA-DRB1 Chains (HLA DRB1)IBA 01/2015
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2015
1	Annexin A1IBA 08/2014
1	ProteomeIBA 08/2014
1	IsotopesIBA 08/2014
1	N 30IBA 04/2014
1	AdrenomedullinIBA 04/2014
1	Cysteine (L-Cysteine)FDA Link 03/2014
1	Oral ContraceptivesIBA 04/2013
1	GlycolipidsIBA 01/2013
1	ProteolipidsIBA 01/2013
1	Interleukin-10 (Interleukin 10)IBA 05/2012
1	CytokinesIBA 05/2012
1	Myelin Basic ProteinIBA 01/2012
1	Toll-Like Receptor 3IBA 05/2010
1	Leukemia Inhibitory FactorIBA 05/2009
1	Leukocyte Common Antigens (CD45 Antigen)IBA 02/2009
1	Myelin ProteinsIBA 05/2008
1	AmidesIBA 02/2008
1	MicellesIBA 02/2008
1	VaccinesIBA 02/2008
1	LipopeptidesIBA 02/2008
1	LipidsIBA 02/2008
1	HLA-DR2 Antigen (HLA DR2 Antigen)IBA 11/2006
1	G(M1) GangliosideIBA 05/2005
1	Neurotransmitter Agents (Neurotransmitter)IBA 02/2005
1	ChemokinesIBA 09/2004
1	Chemokine ReceptorsIBA 09/2004
1	G(M3) GangliosideIBA 01/2003
1	IronIBA 05/2002
1	FrataxinIBA 05/2002

Therapy/Procedure

2	Therapeutics 10/2017 - 04/2013